Profile Core value Main business Legitimacy Social Responsibility
    Patents Research Direction Technology Strength
  API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
  Production management QC Quality System branch factory




  Products Center
Paclitaxel (Semi-synthetic)
Paclitaxel (Natural)
Docetaxel Anhydrous
Docetaxel Trihydrate
Irinotecan HCl Trihydrate 99.5%
Etoposide USP31
Palonosetron Hydrochloride
  N-1 stage of Paclitaxel and Docetaxel
  Main Intermediates
10-Deacetylbaccatin III
Baccatin III
  Side chain for Paclixel semi-Synthetic
(4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain of Docetaxel
(4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain for Paclitaxel and Docetaxel
Ethyl (2R,3S)-3-Phenylisoserine Ester
Your location:Home>>R & D >>Patents

Jinhe dedicates itself to the development of industrialization technology for Anti-cancer drugs with our own intellectual property rights. Currently Jinhe owns three patents as below:

 One of Irinotecan’s Intermediates & its Preparation method and preparation Method Of Irinotecan
Patent Number: ZL 2007 1 004 1525.X
Issue Date: Oct. 27, 2010

 A Synthetic method of Docetaxel
Patent Number: ZL 2006 1 0116735.6
Issue Date: 30 July, 2008

 A method of Extracting and Purifying 10- Deacetyl Baccatin III
Patent Number: ZL 03 1 29635.1
Issue Date: 18 May, 2005

Jinhe is actively applying other patents by its own technique, aiming at more self-developed intellectual properties to pave the way for long term development.

CopyRight(C)2006,Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
HOME About us Products R & D Production and QA Contact us CHINESE
疯狂之七电子游戏 秒速飞艇开奖 十一选五遗漏甘肃 哪个真人棋牌平台好 彩票软件大全 3d万能AB两组六码必出 花卉种植什么最赚钱 掌乐天天捕鱼易玩网 重庆时时二期全天计划 时时彩平台评测网 三分冠军pk10计划网页 黑龙江快乐10分任3 前三组选包胆啥意思 重庆时时人工全天计划 全天北京pk10计划 投币机赚钱吗 wow捕鱼大师的工具箱